A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

NCT04583995 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15185

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection
COVID-19

Interventions

BIOLOGICAL: SARS-CoV-2 rS/Matrix M1-Adjuvant
OTHER: Placebo
BIOLOGICAL: Licensed seasonal influenza vaccine

Sponsor

Novavax